Form 4 for ABT Abbott Laboratories
Accepted 2025-04-29 00:00:00 ET · period of report 2025-04-25 · accession 0001415889-25-011528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-29 | 2025-04-25 | ABT | STARKS DANIEL J | Dir | A - Grant | $0.00 | +1,635 | 6.73M | +0.0% | $0 |
| D | 2025-04-29 | 2025-04-25 | ABT | STARKS DANIEL J | Dir | A - Grant | $0.00 | +4,516 | 4,516 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2025-04-25 | A | A | 1,635 | $0.00 | 6,728,817 | D | — | — | (F1) These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). |
| 2 | Derivative | Option (right to buy) | 2025-04-25 | A | A | 4,516 | $0.00 | 4,516 | D | $128.40 · 2025-04-25 to 2035-04-24 | 4,516 Common Shares | (F3) Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |